List of Studies ( Metabolite:Fluvoxamine)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST001876 | AN003038 | Metabolomics analysis of multiple samples on Agilent 6546-Part 2 | Feces | Mouse | Dalian Institute Of Chemical Physics | blank-substracted abundances | |
| ST001876 | AN003038 | Metabolomics analysis of multiple samples on Agilent 6546-Part 2 | Liver | Mouse | Dalian Institute Of Chemical Physics | blank-substracted abundances | |
| ST001874 | AN003036 | Metabolomics analysis of multiple samples on Agilent 6546-Part 1 | Blood | Human | Dalian Institute Of Chemical Physics | peak area | |
| ST001874 | AN003036 | Metabolomics analysis of multiple samples on Agilent 6546-Part 1 | Hep G2 cells | Human | Dalian Institute Of Chemical Physics | peak area | |
| ST001874 | AN003036 | Metabolomics analysis of multiple samples on Agilent 6546-Part 1 | Urine | Human | Dalian Institute Of Chemical Physics | peak area | |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
| ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
| ST002094 | AN003422 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
| ST002089 | AN003412 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Blood | Human | COPD | National Jewish Health | relativeMedian |
